Variability within the human TERT gene, telomere length and predisposition to chronic lymphocytic leukemia

References

• Chiorazzi N, Rai KR, Ferrarini M. Chronic lymphocytic leukemia. N Engl J Med. 2005;352(8):804–815. doi:10.1056/NEJMoa04097515728813
   PubMed Web of Science ®Google Scholar
• Rodríguez-Vicente AE, Díaz MG, Hernández-Rivas JM. Chronic lymphocytic leukemia: a clinical and molecular heterogenous disease. Cancer Genet. 2013;206(3):49–62. doi:10.1016/j.cancergen.2013.01.00323531595
   PubMed Web of Science ®Google Scholar
• Friedman DR, Lucas JE, Weinberg JB. Clinical and biological relevance of genomic heterogeneity in chronic lymphocytic leukemia. PLoS One. 2013;8(2):e57356. doi:10.1371/journal.pone.005735623468975
   PubMed Web of Science ®Google Scholar
• Karakosta M, Delicha EM, Kouraklis G, Manola KN. Association of various risk factors with chronic lymphocytic leukemia and its cytogenetic characteristics. Arch Environ Occup Health. 2016;71(6):317–329. doi:10.1080/19338244.2015.111642926566973
   PubMed Web of Science ®Google Scholar
• Kasar S, Brown JR. Mutational landscape and underlying mutational processes in chronic lymphocytic leukemia. Mol Cell Oncol. 2016;3(4):e1157667. doi:10.1080/23723556.2016.115766727652313
   PubMedGoogle Scholar
• Berndt SI, Camp NJ, Skibola CF, et al. Meta-analysis of genome-wide association studies discovers multiple loci for chronic lymphocytic leukemia. Nat Commun. 2016;9(7):10933. doi:10.1038/ncomms10933
   Google Scholar
• Law PJ, Berndt SI, Speedy HE, et al. Genome-wide association analysis implicates dysregulation of immunity genes in chronic lymphocytic leukaemia. Nat Commun. 2017;6(8):14175. doi:10.1038/ncomms14175
   Google Scholar
• Speedy HE, Di Bernardo MC, Sava GP, et al. A genome-wide association study identifies multiple susceptibility loci for chronic lymphocytic leukemia. Nat Genet. 2014;46(1):56–60. doi:10.1038/ng.284324292274
   PubMed Web of Science ®Google Scholar
• Hoxha M, Fabris S, Agnelli L, et al. Relevance of telomere/telomerase system impairment in early stage chronic lymphocytic leukemia. Genes Chromosomes Cancer. 2014;53(7):612–621. doi:10.1002/gcc.2217124706380
   PubMed Web of Science ®Google Scholar
• Roos G, Kröber A, Grabowski P, et al. Short telomeres are associated with genetic complexity, high-risk genomic aberrations, and short survival in chronic lymphocytic leukemia. Blood. 2008;111(4):2246–2252. doi:10.1182/blood-2007-05-09275918045969
   PubMed Web of Science ®Google Scholar
• Mansouri L, Grabowski P, Degerman S, et al. Short telomere length is associated with NOTCH1/SF3B1/TP53 aberrations and poor outcome in newly diagnosed chronic lymphocytic leukemia patients. Am J Hematol. 2013;88(8):647–651. doi:10.1002/ajh.2346623620080
   PubMed Web of Science ®Google Scholar
• Rampazzo E, Bonaldi L, Trentin L, et al. Telomere length and telomerase levels delineate subgroups of B-cell chronic lymphocytic leukemia with different biological characteristics and clinical outcomes. Haematologica. 2012;97(1):56–63. doi:10.3324/haematol.2011.04987421933855
   PubMed Web of Science ®Google Scholar
• Medves S, Auchter M, Chambeau L, et al. A high rate of telomeric sister chromatid exchange occurs in chronic lymphocytic leukaemia B-cells. Br J Haematol. 2016;174(1):57–70. doi:10.1111/bjh.1399526970083
   PubMed Web of Science ®Google Scholar
• Poole JC, Andrews LG, Tollefsbol TO. Activity, function, and gene regulation of the catalytic subunit of telomerase (hTERT). Gene. 2001;269(1–2):1–12.11376932
   PubMed Web of Science ®Google Scholar
• Machiela MJ, Lan Q, Slager SL, et al. Genetically predicted longer telomere length is associated with increased risk of B-cell lymphoma subtypes. Hum Mol Genet. 2016;25(8):1663–1676. doi:10.1093/hmg/ddw02727008888
   PubMed Web of Science ®Google Scholar
• Ojha J, Codd V, Nelson CP, et al. ENGAGE consortium telomere group. genetic variation associated with longer telomere length increases risk of chronic lymphocytic leukemia. Cancer Epidemiol Biomarkers Prev. 2016;25(7):1043–1049. doi:10.1158/1055-9965.EPI-15-132927197291
   PubMed Web of Science ®Google Scholar
• Berndt SI, Skibola CF, Joseph V, et al. Genome-wide association study identifies multiple risk loci for chronic lymphocytic leukemia. Nat Genet. 2013;45(8):868–876. doi:10.1038/ng.265223770605
   PubMed Web of Science ®Google Scholar
• Mocellin S, Verdi D, Pooley KA, et al. Telomerase reverse transcriptase locus polymorphisms and cancer risk: a field synopsis and meta-analysis. J Natl Cancer Inst. 2012;104(11):840–854. doi:10.1093/jnci/djs22222523397
   PubMedGoogle Scholar
• Ropio J, Merlio JP, Soares P, Chevret E. Telomerase activation in hematological malignancies. Genes (Basel). 2016;7(9):pii:E61. doi:10.3390/genes7090061
   PubMed Web of Science ®Google Scholar
• Zhdanov DD, Vasina DA, Grachev VA, et al. Alternative splicing of telomerase catalytic subunit hTERT generated by apoptotic endonuclease EndoG induces human CD4+ T cell death. Eur J Cell Biol. 2017;96(7):653–664. doi:10.1016/j.ejcb.2017.08.00428886883
   PubMed Web of Science ®Google Scholar
• Zhdanov DD, Gladilina YA, Pokrovskaya MV, et al. Induction of alternative splicing and inhibition of activity of telomerase catalytic subunit by apoptotic endonuclease EndoG in human T, B, and NK cells. Bull Exp Biol Med. 2018;164(4):478–482. doi:10.1007/s10517-018-4016-y29504103
   PubMed Web of Science ®Google Scholar
• Ghosh A, Saginc G, Leow SC, et al. Telomerase directly regulates NF-κB-dependent transcription. Nat Cell Biol. 2012;14(12):1270–1281. doi:10.1038/ncb246423159929
   PubMed Web of Science ®Google Scholar
• Heidenreich B, Kumar R. Altered TERT promoter and other genomic regulatory elements: occurrence and impact. Int J Cancer. 2017;141(5):867–876. doi:10.1002/ijc.3073528407294
   PubMed Web of Science ®Google Scholar
• Wang L, Soria JC, Chang YS, et al. Association of a functional tandem repeats in the downstream of human telomerase gene and lung cancer. Oncogene. 2003;22(46):7123–7129. doi:10.1038/sj.onc.120685214562040
   PubMed Web of Science ®Google Scholar
• Hofer P, Zöchmeister C, Behm C, et al. MNS16A tandem repeat minisatellite of human telomerase gene: functional studies in colorectal, lung and prostate cancer. Oncotarget. 2017;8(17):28021–28027. doi:10.18632/oncotarget.1588428427205
   PubMedGoogle Scholar
• Zhang Y, Zhang H, Zhai Y, et al. A functional tandem-repeats polymorphism in the downstream of TERT is associated with the risk of nasopharyngeal carcinoma in Chinese population. BMC Med. 2011;9:1–9. doi:10.1186/1741-7015-9-10621219637
   PubMed Web of Science ®Google Scholar
• Wysoczanska B, Wrobel T, Dobrzynska O, Mazur G, Bogunia-Kubik K. Role of the functional MNS16A VNTR- 243 variant of the human telomerase reverse transcriptase gene in progression and response to therapy of patients with non-Hodgkin’s B-cell lymphomas. Int J Immunogenet. 2015;42(2):100–105. doi:10.1111/iji.2015.42.issue-225684018
   PubMed Web of Science ®Google Scholar
• Concetti F, Lucarini N, Carpi FM, et al. The functional VNTR MNS16A of the TERT gene is associated with human longevity in a population of Central Italy. Exp Gerontol. 2013;48(6):587–592. doi:10.1016/j.exger.2013.03.00923562826
   PubMed Web of Science ®Google Scholar
• Chen P, Zou P, Yan Q, et al. The TERT MNS16A polymorphism contributes to cancer susceptibility: meta-analysis of the current studies. Gene. 2013;519(2):266–270. doi:10.1016/j.gene.2013.02.01823462332
   PubMed Web of Science ®Google Scholar
• Xia X, Rui R, Quan S, et al. MNS16A tandem repeats minisatellite of human telomerase gene and cancer risk: a meta-analysis. PLoS One. 2013;8(8):e73367. doi:10.1371/journal.pone.007336723991190
   PubMed Web of Science ®Google Scholar
• Fabbri G, Dalla-Favera R. The molecular pathogenesis of chronic lymphocytic leukaemia. Nat Rev Cancer. 2016;16(3):145–162. doi:10.1038/nrc.2016.826911189
   PubMed Web of Science ®Google Scholar
• Codd V, Nelson CP, Albrecht E, et al. Identification of seven loci affecting mean telomere length and their association with disease. Nat Genet. 2013;45(4):422–427. doi:10.1038/ng.252823535734
   PubMed Web of Science ®Google Scholar
• Guieze R, Wu CJ. Genomic and epigenomic heterogeneity in chronic lymphocytic leukemia. Blood. 2015;126(4):445–453. doi:10.1182/blood-2015-02-58504226065654
   PubMed Web of Science ®Google Scholar
• Rai KR, Sawitsky A, Cronkite EP, et al. Clinical staging of chronic lymphocytic leukemia. Blood. 1975;46(2):219–234.1139039
   PubMed Web of Science ®Google Scholar
• Binet JL, Auquier A, Dighiero G, et al. A new prognostic classification of chronic lymphocytic leukemia derived from a multivariate survival analysis. Cancer. 1981;48(1):198–204.7237385
   PubMed Web of Science ®Google Scholar
• Jebaraj BM, Kienle D, Lechel A, et al. Telomere length in mantle cell lymphoma. Blood. 2013;121(7):1184–1187. doi:10.1182/blood-2012-08-45264923243283
   PubMed Web of Science ®Google Scholar
• Dos Santos P, Panero J, Palau Nagore V, et al. Telomere shortening associated with increased genomic complexity in chronic lymphocytic leukemia. Tumour Biol. 2015;36(11):8317–8324. doi:10.1007/s13277-015-3556-226008147
   PubMedGoogle Scholar
• Hofer P, Baierl A, Feik E, et al. MNS16A tandem repeats minisatellite of human telomerase gene: a risk factor for colorectal cancer. Carcinogenesis. 2011;32(6):866–871. doi:10.1093/carcin/bgr05321422235
   PubMed Web of Science ®Google Scholar
• Hofer P, Zerelles J, Baierl A, et al. MNS16A tandem repeat minisatellite of human telomerase gene and prostate cancer susceptibility. Mutagenesis. 2013;28(3):301–306. doi:10.1093/mutage/get00323423318
   PubMed Web of Science ®Google Scholar
• Andersson U, Osterman P, Sjöström S, et al. MNS16A minisatellite genotypes in relation to risk of glioma and meningioma and to glioblastoma outcome. Int J Cancer. 2009;125(4):968–972. doi:10.1002/ijc.2436319405125
   PubMed Web of Science ®Google Scholar
• Carpentier C, Lejeune J, Gros F, et al. Association of telomerase gene hTERT polymorphism and malignant gliomas. J Neurooncol. 2007;84(3):249–253. doi:10.1007/s11060-007-9378-317410334
   PubMed Web of Science ®Google Scholar
• Steinbrecher D, Jebaraj BMC, Schneider C, et al. Telomere length in poor-risk chronic lymphocytic leukemia: associations with disease characteristics and outcome. Leuk Lymphoma. 2018;59(7):1614–1623. doi:10.1080/10428194.2017.139023629063805
   PubMed Web of Science ®Google Scholar
• Haycock PC, Burgess S, Nounu A, et al. Association between telomere length and risk of cancer and non-neoplastic diseases: a mendelian randomization study. Telomeres mendelian randomization collaboration. JAMA Oncol. 2017;3(5):636–651. doi:10.1001/jamaoncol.2016.594528241208
   PubMed Web of Science ®Google Scholar
• Palma M, Parker A, Hojjat-Farsangi M, et al. Telomere length and expression of human telomerase reverse transcriptase splice variants in chronic lymphocytic leukemia. Exp Hematol. 2013;41(7):615–626. doi:10.1016/j.exphem.2013.03.00823548418
   PubMed Web of Science ®Google Scholar
• Anczuków O, Krainer AR. Splicing-factor alterations in cancers. Rna. 2016;22(9):1285–1301. doi:10.1261/rna.059303.11627530828
   PubMed Web of Science ®Google Scholar
• Puente XS, Beà S, Valdés-Mas R, et al. Non-coding recurrent mutations in chronic lymphocytic leukaemia. Nature. 2015;526(7574):519–524. doi:10.1038/nature1466626200345
   PubMed Web of Science ®Google Scholar
• Jin G, Yoo SS, Cho S, et al. Dual roles of a variable number of tandem repeat polymorphism in the TERT gene in lung cancer. Cancer Sci. 2011;102(1):144–149. doi:10.1111/j.1349-7006.2010.01782.x21083788
   PubMed Web of Science ®Google Scholar
• Scarabino D, Broggio E, Gambina G, et al. Common variants of human TERT and TERC genes and susceptibility to sporadic Alzheimers disease. Exp Gerontol. 2017;88:19–24. doi:10.1016/j.exger.2016.12.01728039025
   PubMed Web of Science ®Google Scholar
• Essa ES, Alagizy HA. Association of MNS16A VNTR and hTERT rs2736098: G>A polymorphisms with susceptibility to diffuse large B-cell lymphoma. Tumori. 2018;104(3):165–171. doi:10.5301/tj.500065328967095
   PubMed Web of Science ®Google Scholar
• Zagouri F, Sergentanis TN, Gazouli M, et al. HTERT MNS16A polymorphism in breast cancer: a case–control study. Mol Biol Rep. 2012;39(12):10859–10863.23065203
   PubMed Web of Science ®Google Scholar
• Lin TT, Letsolo BT, Jones RE, et al. Telomere dysfunction and fusion during the progression of chronic lymphocytic leukemia: evidence for a telomere crisis. Blood. 2010;116(111):1899–1907. doi:10.1182/blood-2010-02-27210420538793
   PubMedGoogle Scholar
• Sellmann L, de Beer D, Bartels M, et al. Telomeres and prognosis in patients with chronic lymphocytic leukaemia. Int J Hematol. 2011;93(1):74–82. doi:10.1007/s12185-010-0750-221203871
   PubMed Web of Science ®Google Scholar
• Sellmann L, Scholtysik R, de Beer D, et al. Shorter telomeres correlate with an increase in the number of uniparental disomies in patients with chronic lymphocytic leukemia. Leuk Lymphoma. 2016;57(3):590–595. doi:10.3109/10428194.2015.107692926457386
   PubMed Web of Science ®Google Scholar
• Lin TT, Norris K, Heppel NH, et al. Telomere dysfunction accurately predicts clinical outcome in chronic lymphocytic leukaemia, even in patients with early stage disease. Br J Haematol. 2014;167(2):214–223. doi:10.1111/bjh.1302324990087
   PubMed Web of Science ®Google Scholar
• Snetselaar R, van Oosterhout MFM, Grutters JC, van Moorsel CHM. Telomerase reverse transcriptase polymorphism rs2736100: a balancing act between cancer and non-cancer disease, a meta-analysis. Front Med. (Lausanne). 2018;5:41. doi:10.3389/fmed.2018.0004129536006
   PubMed Web of Science ®Google Scholar
• Dahlström J, Liu T, Yuan X, et al. TERT rs2736100 genotypes are associated with differential risk of myeloproliferative neoplasms in Swedish and Chinese male patient populations. Ann Hematol. 2016;95(11):1825–1832. doi:10.1007/s00277-016-2787-727561898
   PubMed Web of Science ®Google Scholar